34th International Austrian Winter Symposium

The 34th International Austrian Winter Symposium took place from the 22nd to the 25th of January 2020 in picturesque Zell am See, Austria. The symposium was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging (OGNMB) and was held under the auspices of our this year’s Congress President Ora Israel from Haifa, Israel. […]

SNMMI TV in Vienna

The LBI Applied Diagnostics was part of a collaboration together with the Division of Nuclear Medicine at the Medical University of Vienna and the Christian Doppler Labor for Applied Metabolomics at the annual meeting of the SNMMI in Anaheim, California in 2019. In preperation for the congress, the team of WebsEdge who are partnering with SNMMI visited […]

Neue Studie im Top-Journal „Journal for ImmunoTherapy of Cancer“

Johannes Längle, Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie, belegte zusammen mit WissenschafterInnen des Comprehensive Cancer Center (CCC) der MedUni Wien und des AKH Wien, dass Histon-Deazetylase-Inhibitoren (HDACi) in Kombination mit dem Wirkstoff Trastuzumab die körpereigene Immunabwehr in Form der Phagozytose („Auffressen“) von Brustkrebszellen positiv verstärken. Die Studie wurde unter anderem im Rahmen des […]

Awarded DOC fellowship

We are very proud to announce that Loan Tran, PhD student of the program line Molecular Pathology, was awarded a DOC grant by the Austrian Academy of Sciences (ÖAW) to fund the continuation of her PhD project’s research on colorectal cancer.

New Chelator for Radiolabelling

In a joint research effort supported by the Swiss National Science Foundation, the groups of Prof. Gilles Gasser (Chimie ParisTech) and Prof. Thomas Mindt (LBIAD) have developed a new chelator for the radiolabelling of antibodies and other molecules with the PET radiometal zirconium-89.[1] The new chelator, termed DFO*, provides 89Zr-complexes that are extraordinarily stable in […]

2nd Scientific Advisory Board Meeting

A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had their second meeting with the SAB last week on the 13th of May 2019. The SAB consists of five internationally renowned experts, which were again invited to review our institute’s research, to evaluate our progress […]

Keio University

Japan – One Year Later

By Loan Tran, PhD student, PL Molecular Pathology, Egger group Internship (05.02.18-30.03.18) at Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan Founded in 1858, Keio is one of the most prestigious private universities in Japan. Exactly one year ago, I had the honor to join the laboratory of Assoc. Prof. Yoshimasa Saito and […]

13th OGNMB Congress in January 2019

The 13th National OGNMB Congress took place from the 23rd to the 25th of January 2019 in Zell am See (Austria), a township in the state of Salzburg with 9852 citizens. Zell am See is loved as a destination thoughout the whole year, since it offers great possibilities for skiing and other wintersports as well […]

Markus Zeitlinger received several grants

Congratulations to Markus Zeitlinger, head of the Department of Clinical Pharmacology and key researcher of LBI:AD’s program line Clinical Applications. He received several grants for projects within the „AMR Accelerator Program“ of the Innovative Medicine Initiative (IMI). The Initiative supports studies targeting the investigation of multi-drug resistance to antibiotics. Read more >>here<<